Abstract: | The title compound [systematic name: 4‐amino‐5‐cyano‐1‐(β‐d ‐ribofuranosyl)‐7H‐pyrrolo[2,3‐d]pyrimidine hemihydrate], C12H13N5O4·0.5H2O, is a regioisomer of toyocamycin with the ribofuranosyl residue attached to the pyrimidine moiety of the heterocycle. This analogue exhibits a syn glycosylic bond conformation with a χ torsion angle of 57.51 (17)°. The ribofuranose moiety shows an envelope C2′‐endo (2E) sugar conformation (S‐type), with P = 161.6 (2)° and τm = 41.3 (1)°. The conformation at the exocyclic C4′—C5′ bond is +sc (gauche, gauche), with a γ torsion angle of 54.4 (2)°. The crystal packing is stabilized by intermolecular O—H...O, N—H...N and O—H...N hydrogen bonds; water molecules, located on crystallographic twofold axes, participate in interactions. An intramolecular O—H...N hydrogen bond stabilizes the syn conformation of the nucleoside. |